Top

Published in:

01-12-2019 | Mastectomy | ASO Author Reflections

ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options—A Complex Decision

Authors: Anita Mamtani, MD, Kimberly J. Van Zee, MS, MD

Published in: Annals of Surgical Oncology | Issue 13/2019

Excerpt

Treatment options for ductal carcinoma in situ (DCIS) include breast-conserving surgery (BCS), BCS with adjuvant irradiation or endocrine therapy or both, and mastectomy. When extent of disease permits oncologically safe selection of various approaches, patient decision making may be complex. Concerns about perceived risk of locoregional recurrence (LRR) have been shown to significantly influence patient decisions, but quality-of-life considerations are also important.1 The goal of preoperative treatment planning should be to help a woman optimally weigh LRR risk and quality-of-life issues for the various options.2 …

Katz SJ, Lantz PM, Janz NK, et al. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol. 2005;23(13):3001–7.CrossRef

Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.CrossRef

Rutter CE, Park HS, Killelea BK, Evans SB. Growing use of mastectomy for ductal carcinoma-in situ of the breast among young women in the United States. Ann Surg Oncol. 2015;22(7):2378–86.CrossRef

Cronin PA, Olcese C, Patil S, Morrow M, Van Zee KJ. Impact of age on risk of recurrence of ductal carcinoma in situ: outcomes of 2996 women treated with breast-conserving surgery over 30 years. Ann Surg Oncol. 2016;23(9):2816–24.CrossRef

Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M. Relationship between margin width and recurrence of ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg. 2015;262(4):623–31.PubMedPubMedCentral

Mamtani A, Nakhlis F, Downs-Canner S, et al. Impact of age on locoregional and distant recurrence after mastectomy for ductal carcinoma in situ with or without microinvasion. Ann Surg Oncol. (2019) https://doi.org/10.1245/s10434-019-07693-1.CrossRefPubMed

Title: ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options—A Complex Decision
Authors: Anita Mamtani, MD
Kimberly J. Van Zee, MS, MD
Publication date: 01-12-2019
Publisher: Springer International Publishing
Keyword: Mastectomy
Published in: Annals of Surgical Oncology / Issue 13/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-019-07859-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options—A Complex Decision

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 13/2019

Association Between Preoperative Muscle Mass and Intraoperative Bacterial Translocation in Patients Undergoing Hepatectomy, Pancreatoduodenectomy, and Esophagectomy

Editorial: A Novel Monoclonal Antibody-Targeting Angiogenesis by Inhibiting Secreted Frizzled-Related Protein 2

Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis

Clinical Implications of Conversion Surgery After Induction Therapy for T4b Thoracic Esophageal Squamous Cell Carcinoma

Comparison of Tissue and Blood Concentrations of Oxaliplatin Administrated by Different Modalities of Intraperitoneal Chemotherapy

Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study